MTOR and clear cell renal carcinoma: Through the transcriptional regulation of PDGFB, Syafruddin et al. [12] discovered that KLF6 activated the mTOR signaling pathway and affected lipid metabolism, thereby promoting the progression of renal clear cell carcinoma.